Neurallys startup

Hydrocephalus is a pathology caused by an accumulation of cerebrospinal fuild within the brain and resulting in abnormal intracranial pressure. The most common treatment used today requires surgery to implant a shunt system. Neurallys is developing  a very innovative medical device to improve the quality of life of those patients and provide the neurosurgeons with a new tool for aided-diagnosis and pathology follow-up, with health cost reduction objectives.

Latest News

Neurallys, one of the seven start-ups to join the French Tech Tour Israel 2017

Date: 30-05-2017

For this second tour, seven start-ups specialized in medical devices, biotech and e- health were selected by a judging panel of French and Israeli healthcare experts. They will receive dedicated support for a period of three months, including a...

Read more

Neurallys winner of the Soft Landing Boston Program 2017

Date: 25-04-2017

In an initial round that took place in February, a group of 13 companies was chosen out of 24 startups and SMES that applied. They had the opportunity to pitch to a bilateral expert judging panel composed of healthcare...

Read more

An interview of Neurallys in the Entreprendre Magazine

Date: 17-10-2016

An interview of Neurallys can be read in the Entreprendre French Magazine of October 2016

Read more